Related Experiment Videos
Interaction between nitric oxide and cyclooxygenase pathways in endothelial cells
Cristina Vassalle1, Claudio Domenici, Valter Lubrano
1Institute of Clinical Physiology, CNR, Pisa, Italy. cristina.vassalle@ifc.cnr.it
Journal of Vascular Research
|October 30, 2003
Summary
Nitric oxide (NO) and prostaglandin (PG) pathways interact in blood vessels. Increased PGs were observed with NO donors, while inhibiting cyclooxygenase (COX) enhanced NO production, suggesting complex cross-talk.
Area of Science:
- Endothelial cell biology
- Vascular physiology
- Biochemical signaling pathways
Background:
- Nitric oxide (NO) and cyclooxygenase (COX) derived prostaglandins (PGs) are crucial for vascular homeostasis.
- Previous studies on the interaction between NO and PG pathways have yielded conflicting results.
- Understanding this cross-talk is vital for elucidating vascular regulatory mechanisms.
Purpose of the Study:
- To investigate the interaction between NO and PG release in human microvascular endothelial cells (HMEC-1) and umbilical vein endothelial cells (HUVEC).
- To clarify the cross-talk between the NO and COX pathways in endothelial cells.
Main Methods:
- Assessed nitrite/nitrate (NOx) and L-citrulline for NO production markers.
- Measured prostaglandin E2 (PGE2) and 6-keto-prostaglandin F1alpha as indicators of COX activity.
- Utilized NO donors, L-arginine, L-NMMA, and indomethacin to modulate pathways in HMEC-1 and HUVEC.
Main Results:
- NO donors and L-arginine elevated PG levels in both cell types.
- N(G)-monomethyl-L-arginine (L-NMMA) inhibited 6-keto-PGF1alpha but not PGE2.
- Indomethacin increased NOx, eNOS, and L-citrulline levels; PGE2 did not affect NOx.
Conclusions:
- NO stimulation of PGs may contribute to vasodilation by nitrovasodilators.
- COX inhibition led to compensatory increases in NO production.
- PGs did not compensate for reduced NO levels induced by L-NMMA.